EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H25N3O |
| Net Charge | 0 |
| Average Mass | 347.462 |
| Monoisotopic Mass | 347.19976 |
| SMILES | O=C(NC1CCN(CCc2cnc3ccccc23)CC1)c1ccccc1 |
| InChI | InChI=1S/C22H25N3O/c26-22(17-6-2-1-3-7-17)24-19-11-14-25(15-12-19)13-10-18-16-23-21-9-5-4-8-20(18)21/h1-9,16,19,23H,10-15H2,(H,24,26) |
| InChIKey | JXZZEXZZKAWDSP-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Application: | antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| indoramin (CHEBI:135470) has role antihypertensive agent (CHEBI:35674) |
| indoramin (CHEBI:135470) is a indoles (CHEBI:24828) |
| indoramin (CHEBI:135470) is a organic molecular entity (CHEBI:50860) |
| indoramin (CHEBI:135470) is a tryptamines (CHEBI:27162) |
| INN | Source |
|---|---|
| indoramina | WHO MedNet |
| Synonyms | Source |
|---|---|
| Indoramin | ChEMBL |
| indoramine | DrugCentral |
| Wy 21901 | DrugCentral |
| Wy-21901 | DrugCentral |
| Wy21901 | DrugCentral |
| Brand Names | Source |
|---|---|
| Baratol | ChEMBL |
| Doralese tiltab | ChEMBL |
| Manual Xrefs | Databases |
|---|---|
| 1443 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| CAS:26844-12-2 | DrugCentral |
| Citations |
|---|